Cargando…
Lung Cancer Combination Treatment: Evaluation of the Synergistic Effect of Cisplatin Prodrug, Vinorelbine and Retinoic Acid When Co-Encapsulated in a Multi-Layered Nano-Platform
PURPOSE: Lung cancer remains the leading cancer-associated deaths worldwide. Cisplatin (CIS) was often used in combination with other drugs for the treatment of non-small cell lung cancer (NSCLC). Prodrug is an effective strategy to improve the efficiency of drugs and reduce the toxicity. The aim of...
Autores principales: | Liang, Zhen, Li, Juan, Zhu, Budong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602907/ https://www.ncbi.nlm.nih.gov/pubmed/33149550 http://dx.doi.org/10.2147/DDDT.S251749 |
Ejemplares similares
-
Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine
por: Hong, Yuan, et al.
Publicado: (2020) -
Conquering Cancer Multi-Drug Resistance Using Curcumin and Cisplatin Prodrug-Encapsulated Mesoporous Silica Nanoparticles for Synergistic Chemo- and Photodynamic Therapies
por: Busa, Prabhakar, et al.
Publicado: (2022) -
Synergistic Effect of Retinoic Acid Polymeric Micelles and Prodrug for the Pharmacodynamic Evaluation of Tumor Suppression
por: Zhu, Yan-Hua, et al.
Publicado: (2019) -
Dynamic crosslinked polymeric nano-prodrugs for highly selective synergistic chemotherapy
por: Wang, Shi, et al.
Publicado: (2022) -
Comparison of vinorelbine with cisplatin in concomitant chemoradiotherapy in head and neck carcinoma
por: Devleena,, et al.
Publicado: (2010)